US Patent 10112923 1,2,4-triazine-4-amine derivatives
Patent 10112923 was granted and assigned to Heptares Therapeutics on October, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 4, 2016
0
Date of Patent
October 30, 2018
0
Patent Applicant
Patent Application Number
15344048
0
Patent Citations Received
•••
Patent Inventor Names
Christine Mary Richardson
0
Jonathan Stephen Mason
0
Miles Stuart Congreve
0
Stephen Philippe Andrews
0
Giles Albert Brown
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10112923 1,2,4-triazine-4-amine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.